Bionano Genomics Inc. (BNGO)
5.34
-0.20 (-3.61%)
At close: Feb 20, 2025, 3:59 PM
5.34
0.00%
After-hours: Feb 20, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 5.21 |
| Market Cap | 12.44M |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -138 |
| PE Ratio (ttm) | -0.04 |
| Forward PE | n/a |
| Analyst | Hold |
| Ask | 5.7 |
| Volume | 107,511 |
| Avg. Volume (20D) | 209,816 |
| Open | 5.58 |
| Previous Close | 5.54 |
| Day's Range | 5.20 - 5.58 |
| 52-Week Range | 4.75 - 81.00 |
| Beta | undefined |
About BNGO
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; and Bionano Prep Kits and DNA labeling kits, which provide the reagents ...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date Aug 21, 2018
Employees 344
Stock Exchange NASDAQ
Ticker Symbol BNGO
Website https://www.bionanogenomics.com
Analyst Forecast
According to 3 analyst ratings, the average rating for BNGO stock is "Hold." The 12-month stock price forecast is $60, which is an increase of 1023.60% from the latest price.
Buy 0.00%
Hold 100.00%
Sell 0.00%
Next Earnings Release
Bionano Genomics Inc. is scheduled to release its earnings on Mar 4, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
-28.66%
Bionano Genomics shares are trading lower after th...
Unlock content with
Pro Subscription
3 months ago
-7.59%
Bionano Genomics shares are trading lower after the company reported worse-than-expected Q3 sales results.
